Lai Shi
Senior Scientist Sanofi
Seminars
Thursday 3rd December 2026
Development of Multiplex qPCR Platform Technology for Gene Therapy Product Potency Assessment
11:45 am
- Transition approaches of a dual-target AAV gene therapy potency assay from two separate reactions to a single multiplex PCR
- Channels independence validation and establishing proper controls
- Analytical performance qualification
